Tango Therapeutics Inc
$ 7.87
-1.75%
07 Nov - close price
- Market Cap 1,059,255,000 USD
- Current Price $ 7.87
- High / Low $ 8.13 / 7.37
- Stock P/E N/A
- Book Value 1.43
- EPS -0.91
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.24 %
- ROE -0.52 %
- 52 Week High 9.70
- 52 Week Low 1.03
About
None
Analyst Target Price
$12.83
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-05 | 2025-05-12 | 2025-02-27 | 2024-11-06 | 2024-08-07 | 2024-05-08 | 2024-03-18 | 2023-11-08 | 2023-08-07 | 2023-05-09 | 2023-03-27 |
| Reported EPS | 0.13 | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.32 | -0.33 |
| Estimated EPS | -0.0719 | -0.35 | -0.3459 | -0.3428 | -0.37 | -0.34 | -0.31 | -0.28 | -0.34 | -0.34 | -0.35 | -0.35 |
| Surprise | 0.2019 | 0 | -0.0141 | 0.0028 | 0.1 | 0.1 | -0.04 | -0.04 | 0.11 | 0.11 | 0.03 | 0.02 |
| Surprise Percentage | 280.8067% | 0% | -4.0763% | 0.8168% | 27.027% | 29.4118% | -12.9032% | -14.2857% | 32.3529% | 32.3529% | 8.5714% | 5.7143% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TNGX
2025-11-06 00:21:36
Image source: The Motley Fool.Wednesday, Nov. 5, 2025 at 4:30 p.m. ETChief Executive Officer - Mark A. GoldsmithContinue reading ...
2025-11-04 15:15:02
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of +1,200.00% and +23.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2025-10-31 14:55:02
The average of price targets set by Wall Street analysts indicates a potential upside of 52.2% in Tango Therapeutics (TNGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
2025-10-31 13:55:02
The average of price targets set by Wall Street analysts indicates a potential upside of 52.2% in Tango Therapeutics (TNGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
2025-10-31 04:39:26
Venture capital fund Third Rock Ventures IV, L.P., a 10% owner of Tango Therapeutics, Inc. ( NASDAQ:TNGX ) , reported the sale of 477,401 shares in an open-market transaction on October 23, 2025, according to an SEC Form 4 filing.Transaction value is based on the SEC Form 4 weighted average ...
2025-10-27 16:00:03
Tango Therapeutics (TNGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
